GE Healthcare Korea to foster biotech
GE Healthcare Life Sciences Korea is planning to provide 2.5 billion won ($2.33 million) in technical and resource support to small- to medium-sized biotech firms that need help developing a biopharmaceutical manufacturing process.
The company has launched the program to lend expertise and research support through the whole production process, which encompasses cell cultivation, purification and screening, process optimization, process scale-up, and sample production for nonclinical studies. The aim is to advance Korea’s biotech industry.
Notably, GE will provide consulting and support on process development to selected applicants. The global healthcare firm will also offer training sessions for researching and developing biologic drugs at GE Healthcare’s APAC Fast Track Center located in Songdo, Incheon, South Korea – a facility used to train biotech professionals and firms improve a production process across the APAC region.